These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 727870)

  • 1. [Use of structure-activity analysis in toxicology].
    Laass W
    Arch Exp Veterinarmed; 1978; 32(4):579-84. PubMed ID: 727870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure activity relationship in toxicology.
    Vereczkey L
    Acta Physiol Hung; 1995; 83(1):47-50. PubMed ID: 7660836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-based modeling applied to characterization and prediction of chemical toxicity.
    Benigni R; Richard AM
    Methods; 1998 Mar; 14(3):264-76. PubMed ID: 9571083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future of toxicology--predictive toxicology: An expanded view of "chemical toxicity".
    Richard AM
    Chem Res Toxicol; 2006 Oct; 19(10):1257-62. PubMed ID: 17040094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of in vitro data in risk assessment.
    Bernauer U; Oberemm A; Madle S; Gundert-Remy U
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):176-81. PubMed ID: 15733212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a neurotoxic equivalence scheme of relative potency for assessing the risk of PCB mixtures.
    Simon T; Britt JK; James RC
    Regul Toxicol Pharmacol; 2007 Jul; 48(2):148-70. PubMed ID: 17475378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive toxicology: benchmarking molecular descriptors and statistical methods.
    Feng J; Lurati L; Ouyang H; Robinson T; Wang Y; Yuan S; Young SS
    J Chem Inf Comput Sci; 2003; 43(5):1463-70. PubMed ID: 14502479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products.
    Kruhlak NL; Contrera JF; Benz RD; Matthews EJ
    Adv Drug Deliv Rev; 2007 Jan; 59(1):43-55. PubMed ID: 17229485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational toxicology in drug development.
    Muster W; Breidenbach A; Fischer H; Kirchner S; Müller L; Pähler A
    Drug Discov Today; 2008 Apr; 13(7-8):303-10. PubMed ID: 18405842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of structure generators in predictive pharmacology and toxicology.
    Wieland T
    Arzneimittelforschung; 1996 Feb; 46(2):223-7. PubMed ID: 8720320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
    Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
    Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory perspectives of Type II prodrug development and time-dependent toxicity management: nonclinical Pharm/Tox analysis and the role of comparative toxicology.
    Wu KM; Farrelly JG
    Toxicology; 2007 Jul; 236(1-2):1-6. PubMed ID: 17507137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of emerging technologies in toxicology and safety assessment.
    Reynolds VL
    Int J Toxicol; 2005; 24(3):135-7. PubMed ID: 16040564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico methods for early toxicity assessment.
    Merlot C
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of molecular, cellular, and genetic neurotoxicology.
    Wallace DR
    Neurol Clin; 2005 May; 23(2):307-20. PubMed ID: 15757786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.